Alaye siwaju sii ― Yoruba

Riehl melanosis ni a mọ́ nigbagbogbo gẹ́gẹ́ bí dermatitis olubasọrọ pigmented. Ó jẹ́ irú àìlera awọ ara tí ó ń ṣẹlẹ̀ nípasẹ̀ àwọn ohun èlò tó ń fà á, púpọ̀ jùlọ nípa lofinda àti àwọn ohun èlò míì tí a máa rí nínú àwọn ọjà ohun ìkúnra. Bó tilẹ̀ jẹ́ pé a kà á sí irú dermatitis, Riehl melanosis ń ṣàfihàn àyípadà àfarawà (pigmentation) lórí awọ ara, pẹ̀lú ààmì kékeré tí ó ń ṣàfihàn ìbànújẹ̀ (irritation) nìkan. Ó wọ́pọ̀ jùlọ ní àárín àwọn ènìyàn tí ó ní awọ dudu. Iwadi àìpẹ̀ ti ṣàwárí pé itọju laser mid‑fluence QSNY 1064‑nm lè dín àfarawà jinlẹ̀ tó ní í ṣe pẹ̀lú Riehl melanosis. Iwadi míì kan ṣàkóso àpapọ̀ àwọn itọju, pẹ̀lú low‑fluence 1064‑nm Q‑switched Nd:YAG laser, ipara hydroquinone, àti tranexamic acid oral, tí ó yọrí sí ìmúra pọ̀ fún ọ̀pọ̀lọpọ̀ aláìsàn.
Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.

Riehl's melanosis jẹ́ àìlera awọ tí ó ń ṣẹlẹ̀ nípasẹ̀ ìbáṣepọ̀ pẹ̀lú àwọn ohun èlò tó ń kó ìfarapa sí ara àti ìfarahan sí ìmọ́lẹ̀ oorun. Ó ń yọrí sí ìdáhùn àìlera, pẹ̀lú àwọ̀ grẹy tó ń bà á lórí awọ ara, tó lè kan àwọn aláìsàn nípa ọpọlọ àti ara. Bí ó tilẹ̀ jẹ́ pé ìdí gangan ti Riehl's melanosis kò tíì dájú, ìwádìí tó wà tẹ́lẹ̀ ti fi hàn pé ó ní ìbáṣepọ̀ tó lágbára pẹ̀lú ìfarahan sí ohun èlò tó ń kó ìfarapa. Fún ìtọ́jú, a ti lo àwọn ọ̀ògùn ibílẹ̀ àti ìtọ́jú láìlérò laser, nígbà míì pẹ̀lú lílo àwọn aṣọ̀ọ̀rọ̀ bleaching tó ń lò sí awọ ara. Ìtọ́jú láìlérò laser, pàápàá jùlọ Q‑switched Nd:YAG laser, ti fi hàn pé ó ní àbájáde tó ń bọ́ síwájú fún ìtọ́jú Riehl's melanosis. Ìṣọ̀kan àwọn ọ̀nà ìtọ́jú tó yàtọ̀ síra ti yọrí sí àbájáde rere.
Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.